App database

AIEOP

ECHELON ITALIA S.R.L.

Store data observed · From public App Store data · How we score apps

  • Medical
  • App Store
  • United States
  • —0 ratings
  • Free download
  • Updated
  • Observed

Ratings

Observed
0

Chart position

Observed
—Not on the top charts

90-day growth

—not enough history yet

Opportunity score

AI-derived
69/100Promising · low confidence
Own AIEOP? Share your real numbers

Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.

Sign in to share them.

Made AIEOP? Add a “Tracked in Medical” badge to your site
Tracked in Medical badge

About AIEOPObserved

AIEOP is a Medical app by ECHELON ITALIA S.R.L. on the United States App Store. Released Oct 6, 2026; last updated Oct 9, 2026 (version 1.0.3). AIEOP is free to download.

MRRBeam rates the success of AIEOP 0/100 (early stage).

App ufficiale per il congresso LI° Congresso Nazionale AIEOP / Lecce, 12-14 ottobre 2026. Tramite l'app avrai facile accesso a tutte le informazioni del congresso: programma aggiornato, sede del congresso, mappa dei luoghi.
From the App Store listing
Success score
0/100 Early stage
In Medical
Outside the top 100
Chart position
Not on the top charts

App Store screenshotsObserved

AIEOP screenshot 1AIEOP screenshot 2
Loading the full report…

AIEOP: common questions

What is AIEOP?
AIEOP is a Medical app developed by ECHELON ITALIA S.R.L., available on the App Store. It was first released on Oct 6, 2026.
How much does AIEOP cost?
AIEOP is free to download.
Is AIEOP successful?
MRRBeam rates the success of AIEOP 0/100 (early stage). The success score combines rating volume, chart position and average rating.
When was AIEOP last updated?
AIEOP was last updated on Oct 9, 2026 (version 1.0.3).
What are alternatives to AIEOP?
Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
Is there room to build a competitor to AIEOP?
MRRBeam's opportunity score for AIEOP is 69/100. A recent launch with a thin review footprint (0 reviews).